Literature DB >> 22580541

Association between colorectal cancer susceptibility loci and survival time after diagnosis with colorectal cancer.

Amanda I Phipps1, Polly A Newcomb, Xabier Garcia-Albeniz, Carolyn M Hutter, Emily White, Charles S Fuchs, Aditi Hazra, Shuji Ogino, Hongmei Nan, Jing Ma, Peter T Campbell, Jane C Figueiredo, Ulrike Peters, Andrew T Chan.   

Abstract

Genome-wide association studies have identified 16 germline single-nucleotide polymorphisms (SNPs) that are associated with colorectal cancer (CRC) incidence. We examined the relationship between these SNPs and survival of 2611 individuals with CRC, enrolled in 5 cohort studies. We used Cox regression analysis to associate SNPs with overall and CRC-specific survival times. The minor allele in rs4939827 (SMAD7) was associated with reduced overall survival (hazard ratio, 1.16; 95% confidence interval, 1.06-1.27; P = .002) and disease-specific survival (hazard ratio, 1.17; 95% confidence interval, 1.05-1.30; P = .005). Other SNPs were not associated significantly with survival. Common germline variations might be prognostic factors for patients with CRC. A variant in SMAD7 could affect progression of CRC.
Copyright © 2012 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22580541      PMCID: PMC3579620          DOI: 10.1053/j.gastro.2012.04.052

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  12 in total

Review 1.  Role of transforming growth factor beta in human disease.

Authors:  G C Blobe; W P Schiemann; H F Lodish
Journal:  N Engl J Med       Date:  2000-05-04       Impact factor: 91.245

2.  Pharmacogenetic predictors of adverse events and response to chemotherapy in metastatic colorectal cancer: results from North American Gastrointestinal Intergroup Trial N9741.

Authors:  Howard L McLeod; Daniel J Sargent; Sharon Marsh; Erin M Green; Cristi R King; Charles S Fuchs; Ramesh K Ramanathan; Stephen K Williamson; Brian P Findlay; Stephen N Thibodeau; Axel Grothey; Roscoe F Morton; Richard M Goldberg
Journal:  J Clin Oncol       Date:  2010-06-07       Impact factor: 44.544

3.  Predictive value of VEGF gene polymorphisms for metastatic colorectal cancer patients receiving first-line treatment including fluorouracil, irinotecan, and bevacizumab.

Authors:  Vincenzo Formica; Raffaele Palmirotta; Girolamo Del Monte; Annalisa Savonarola; Giorgia Ludovici; Maria Laura De Marchis; Italia Grenga; Michele Schirru; Fiorella Guadagni; Mario Roselli
Journal:  Int J Colorectal Dis       Date:  2010-12-29       Impact factor: 2.571

4.  Common germline variation in mismatch repair genes and survival after a diagnosis of colorectal cancer.

Authors:  Thibaud Koessler; Elizabeth M Azzato; Barbara Perkins; Robert J Macinnis; David Greenberg; Douglas F Easton; Paul D P Pharoah
Journal:  Int J Cancer       Date:  2009-04-15       Impact factor: 7.396

5.  Common colorectal cancer risk variants in SMAD7 are associated with survival among prediagnostic nonsteroidal anti-inflammatory drug users: a population-based study of postmenopausal women.

Authors:  Michael N Passarelli; Anna E Coghill; Carolyn M Hutter; Yingye Zheng; Karen W Makar; John D Potter; Polly A Newcomb
Journal:  Genes Chromosomes Cancer       Date:  2011-08-24       Impact factor: 5.006

6.  Ten common genetic variants associated with colorectal cancer risk are not associated with survival after diagnosis.

Authors:  Albert Tenesa; Evropi Theodoratou; Farhat V N Din; Susan M Farrington; Roseanne Cetnarskyj; Rebecca A Barnetson; Mary E Porteous; Harry Campbell; Malcolm G Dunlop
Journal:  Clin Cancer Res       Date:  2010-07-13       Impact factor: 12.531

7.  Functional and clinical significance of variants localized to 8q24 in colon cancer.

Authors:  Mine S Cicek; Susan L Slager; Sara J Achenbach; Amy J French; Hilary E Blair; Stephanie R Fink; Nathan R Foster; Brian F Kabat; Kevin C Halling; Julie M Cunningham; James R Cerhan; Robert B Jenkins; Lisa A Boardman; Gloria M Petersen; Daniel J Sargent; Steven R Alberts; Paul J Limburg; Stephen N Thibodeau
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-08-18       Impact factor: 4.254

8.  FCGR2A and FCGR3A polymorphisms associated with clinical outcome of epidermal growth factor receptor expressing metastatic colorectal cancer patients treated with single-agent cetuximab.

Authors:  Wu Zhang; Michael Gordon; Anne M Schultheis; Dong Yun Yang; Fumio Nagashima; Mizutomo Azuma; Heung-Moon Chang; Eva Borucka; Georg Lurje; Andy E Sherrod; Syma Iqbal; Susan Groshen; Heinz-Josef Lenz
Journal:  J Clin Oncol       Date:  2007-08-20       Impact factor: 44.544

Review 9.  New insights into the aetiology of colorectal cancer from genome-wide association studies.

Authors:  Albert Tenesa; Malcolm G Dunlop
Journal:  Nat Rev Genet       Date:  2009-06       Impact factor: 53.242

10.  Meta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33.

Authors:  Richard S Houlston; Jeremy Cheadle; Sara E Dobbins; Albert Tenesa; Angela M Jones; Kimberley Howarth; Sarah L Spain; Peter Broderick; Enric Domingo; Susan Farrington; James G D Prendergast; Alan M Pittman; Evi Theodoratou; Christopher G Smith; Bianca Olver; Axel Walther; Rebecca A Barnetson; Michael Churchman; Emma E M Jaeger; Steven Penegar; Ella Barclay; Lynn Martin; Maggie Gorman; Rachel Mager; Elaine Johnstone; Rachel Midgley; Iina Niittymäki; Sari Tuupanen; James Colley; Shelley Idziaszczyk; Huw J W Thomas; Anneke M Lucassen; D Gareth R Evans; Eamonn R Maher; Timothy Maughan; Antigone Dimas; Emmanouil Dermitzakis; Jean-Baptiste Cazier; Lauri A Aaltonen; Paul Pharoah; David J Kerr; Luis G Carvajal-Carmona; Harry Campbell; Malcolm G Dunlop; Ian P M Tomlinson
Journal:  Nat Genet       Date:  2010-10-24       Impact factor: 38.330

View more
  32 in total

1.  Common genetic variation and survival after colorectal cancer diagnosis: a genome-wide analysis.

Authors:  Amanda I Phipps; Michael N Passarelli; Andrew T Chan; Tabitha A Harrison; Jihyoun Jeon; Carolyn M Hutter; Sonja I Berndt; Hermann Brenner; Bette J Caan; Peter T Campbell; Jenny Chang-Claude; Stephen J Chanock; Jeremy P Cheadle; Keith R Curtis; David Duggan; David Fisher; Charles S Fuchs; Manish Gala; Edward L Giovannucci; Richard B Hayes; Michael Hoffmeister; Li Hsu; Eric J Jacobs; Lina Jansen; Richard Kaplan; Elisabeth J Kap; Timothy S Maughan; John D Potter; Robert E Schoen; Daniela Seminara; Martha L Slattery; Hannah West; Emily White; Ulrike Peters; Polly A Newcomb
Journal:  Carcinogenesis       Date:  2015-11-19       Impact factor: 4.944

Review 2.  Genetic variations in colorectal cancer risk and clinical outcome.

Authors:  Kejin Zhang; Jesse Civan; Sushmita Mukherjee; Fenil Patel; Hushan Yang
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

3.  A subset of genetic susceptibility variants for colorectal cancer also has prognostic value.

Authors:  S Noci; M Dugo; F Bertola; F Melotti; A Vannelli; T A Dragani; A Galvan
Journal:  Pharmacogenomics J       Date:  2015-05-12       Impact factor: 3.550

4.  Common single-nucleotide polymorphisms in the estrogen receptor β promoter are associated with colorectal cancer survival in postmenopausal women.

Authors:  Michael N Passarelli; Amanda I Phipps; John D Potter; Karen W Makar; Anna E Coghill; Karen J Wernli; Emily White; Andrew T Chan; Carolyn M Hutter; Ulrike Peters; Polly A Newcomb
Journal:  Cancer Res       Date:  2012-11-13       Impact factor: 12.701

5.  Evaluation of genetic variants in association with colorectal cancer risk and survival in Asians.

Authors:  Nan Wang; Yingchang Lu; Nikhil K Khankari; Jirong Long; Hong-Lan Li; Jing Gao; Yu-Tang Gao; Yong-Bing Xiang; Xiao-Ou Shu; Wei Zheng
Journal:  Int J Cancer       Date:  2017-06-21       Impact factor: 7.396

6.  Relationship of prediagnostic body mass index with survival after colorectal cancer: Stage-specific associations.

Authors:  Jonathan M Kocarnik; Andrew T Chan; Martha L Slattery; John D Potter; Jeffrey Meyerhardt; Amanda Phipps; Hongmei Nan; Tabitha Harrison; Thomas E Rohan; Lihong Qi; Lifang Hou; Bette Caan; Candyce H Kroenke; Howard Strickler; Richard B Hayes; Robert E Schoen; Dawn Q Chong; Emily White; Sonja I Berndt; Ulrike Peters; Polly A Newcomb
Journal:  Int J Cancer       Date:  2016-05-14       Impact factor: 7.396

7.  Are SMAD7 rs4939827 and CHI3L1 rs4950928 polymorphisms associated with colorectal cancer in Egyptian patients?

Authors:  Amal Ahmed Abd El-Fattah; Nermin Abdel Hamid Sadik; Olfat Gamil Shaker; Amal Mohamed Kamal
Journal:  Tumour Biol       Date:  2016-01-16

8.  Phenotypic and tumor molecular characterization of colorectal cancer in relation to a susceptibility SMAD7 variant associated with survival.

Authors:  Xabier Garcia-Albeniz; Hongmei Nan; Linda Valeri; Teppei Morikawa; Aya Kuchiba; Amanda I Phipps; Carolyn M Hutter; Ulrike Peters; Polly A Newcomb; Charles S Fuchs; Edward L Giovannucci; Shuji Ogino; Andrew T Chan
Journal:  Carcinogenesis       Date:  2012-10-26       Impact factor: 4.944

9.  Molecular pathological epidemiology gives clues to paradoxical findings.

Authors:  Reiko Nishihara; Tyler J VanderWeele; Kenji Shibuya; Murray A Mittleman; Molin Wang; Alison E Field; Edward Giovannucci; Paul Lochhead; Shuji Ogino
Journal:  Eur J Epidemiol       Date:  2015-10-07       Impact factor: 8.082

Review 10.  Germline determinants of clinical outcome of cutaneous melanoma.

Authors:  Matjaz Vogelsang; Melissa Wilson; Tomas Kirchhoff
Journal:  Pigment Cell Melanoma Res       Date:  2015-11-03       Impact factor: 4.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.